農田合夥基金 FPI 深 滬
等待開盤 08-01 09:30:00 美东时间
10.45
-0.110
-1.04%
華盛通- 最 高10.64
- 今 開10.55
- 成交量 27.39万股
- 最 低 10.435
- 昨 收 10.56
- 總市值 4.81亿
- 52周最高 12.75
- 市盈率 靜 10.37
- 換手率 0.60%
- 52周最低 8.4819
- 委 比 12.83%
- 總股本 4599.00万
- 歷史最高 14.29
- 量 比 0.57
- 振 幅 1.94%
- 歷史最低 1.66
- 每 手 1
- 風險率 1.01%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多EU pharma lobby criticizes potential Trump tariffs on pharmaceuticals
An EU pharma lobby has criticized the Trump administration’s plans to impose 15% tariffs on pharmaceutical imports amid uncertainty over how the newly announced U.S.-EU trade deal targets the product ...
07-29 22:23
Real estate stocks edge up amid strong start to earnings season
Real estate stocks ended the week in green as a strong start to the quarterly earnings season boosted optimism. About 67% of the S&P 500 real estate companies reporting quarterly financial results pos...
07-27 00:00
复旦微电：富国基金、国海证券等多家机构于7月24日调研我司
证券之星消息，2025年7月25日复旦微电（688385）发布公告称富国基金、国海证券、华福证券、华创证券、广发证券、平安养老于2025年7月24日调研我司。
07-25 19:31
Farmland Partners declares $0.06 dividend
Farmland Partners (NYSE:FPI) declares $0.06/share quarterly dividend, in line with previous. Forward yield 2.11% Payable Oct. 15; for shareholders of record Oct. 1; ex-div Oct. 1. See FPI Dividend Sc...
07-24 22:30
Farmland Partners Affirms FY2025 FFO Guidance of $0.28-$0.34 vs $0.32 Est
Farmland Partners (NYSE:FPI) affirms FY2025 FFO guidance from $0.28-$0.34 to $0.28-$0.34 vs $0.32 analyst estimate..
07-24 05:04
Earnings Scheduled For July 23, 2025
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to repor...
07-23 16:32
Earnings Outlook For Farmland Partners
Farmland Partners (NYSE:FPI) is set to give its latest quarterly earnings repor...
07-23 05:02
83%首诊已是肠癌中晚期！无论男女，到了年龄就要做这项检查→
（来源：凯普生物） 转自：凯普生物 “好好的人，之前一点感觉都没有，怎么突然就结直肠癌晚期了呢？” 其实，没有“突然”的癌症，都是慢慢演变的结果。有这么一份数据...
07-16 17:01
七月配置视点：小微盘当下风险几何？| 民生金工
（转自：尔乐量化） ➤小微盘当下风险几何？ 1.2025年上半年，小微盘表现明显强于大盘。中证1000指数、万得小市值指数均明显跑赢沪深30...
07-07 08:31
Pfizer Seeks Label Expansion For Hemophilia Drug After Promising Data
Pfizer's Hympavzi showed superior bleed control in hemophilia A and B patients with inhibitors, reducing bleeding rates and showing good tolerability.
06-27 01:47
